Publication | Closed Access

Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes

Autoimmune DisordersRheumatologyMyelodysplastic Syndrome PatientsHematological MalignancyBone Marrow FailureAutoimmune DiseaseAdverse ImpactLupusAplastic AnemiaImmunologyHematologyAutoimmunityAutoantibodiesImmunologic DiseaseImmunotherapyMedicineRheumatoid ArthritisMyeloid Neoplasia